Headquarters: Clearwater, FL
Status: Active
Industry: Pharma Services
Investment Date: January 2021
Visit Site Status: Active
Industry: Pharma Services
Investment Date: January 2021
Portfolio
Bend Bioscience (fka. CoreRx)
Bend Bioscience (fka. CoreRx) is a CDMO with end-to-end capabilities and specializes in small market molecules and difficult-to-formulate NCEs and 505(b)(2) pathways
Investment Thesis
QHP partnered with Bend Bioscience (fka. CoreRx) to develop a CDMO with end-to-end capabilities that could fill the gap of small batch manufacturers focusing on niche drug formulations with capacity
QHP Value Enhancement
Utilized QHP’s global network of industry experts to drive a steady flow of revenue opportunities
Provided resources and operating partners to bolster go-to-market strategy and allow Bend Bioscience to become best-in-class at bringing drugs from development through commercialization